AnteoTechAnteoTechAnteoTechAnteoTech
  • Home
  • About
    • BOARD OF DIRECTORS
    • MANAGEMENT TEAM
    • ADVISORY BOARDS
  • Life Science
    • ANTEOBIND
      • PUBLICATIONS
    • PRODUCTS
    • CONTRACT SERVICES
    • CASE STUDIES
    • WEBINARS
  • Energy
    • ANTEO X
    • WEBINARS
  • EuGeni
  • Newsroom
  • Investors
    • ASX ANNOUNCEMENTS
    • CORPORATE GOVERNANCE & COMPANY POLICY
    • VIEW ON ASX
  • Customer Login
  • Contact

Spanish and Portuguese Distribution Agreement for EuGeni

    Home Uncategorized Spanish and Portuguese Distribution Agreement for EuGeni
    NextPrevious

    Spanish and Portuguese Distribution Agreement for EuGeni

    By AnteoTech | Uncategorized | 0 comment | 18 October, 2021 |

    AnteoTech broadens European market exposure, securing a Spanish and Portuguese Distribution Agreement for EuGeni

    AnteoTech is pleased to welcome another newly appointed distributor to the EuGeni family. Most recently, AnteoTech has appointed Vitro Master Diagnostica (Vitro) for Spain and Portugal, the sixth exclusive distributor in Europe.

    Following the appointment, Vitro Master Vitro S.A. and its Portuguese subsidiary, Master-InVitro will sell and distribute the EuGeni Reader platform and SARS-CoV-2 Antigen Rapid Diagnostic Test (RDT)  in Spain and Portugal and significantly strengthen AnteoTech’s footprint in Europe.

    Vitro S.A. is a Spanish private corporation specialising in the development, manufacture and distribution of in-vitro diagnostic (IVD) instruments, software and reagents. The group focuses on solutions which use non-invasive techniques such as immunohistochemistry and molecular biology diagnostics, making the EuGeni platform the perfect fit.

    Vitro boast more than 30 years’ of experience in the supply of IVD reagents and platforms to a large number of Spanish hospitals and reference laboratories. Master in-Vitro, the Portuguese subsidiary, has extensive expertise in importing and marketing diagnostic products and services in Portugal.

    AnteoTech will work together with Vitro S.A. and Master-InVitro to fulfil all necessary regulatory registration requirements. In parallel, AnteoTech will provide sales, marketing, and technical training to both parties to ensure a streamlined go-to-market execution.

    AnteoTech CEO Derek Thomson said, “I am excited to be signing a further distributor in Europe. This brings our global distributor count to nine covering 17 distribution territories. Vitro have a strong track record in the IVD space and are perfectly positioned to execute on our EuGeni Platform strategy, placing readers into clinics and laboratories across the two countries.  We have been working with Vitro over the past 6 months as they trialled the EuGeni platform with their customers in Spain, and we are very pleased for them and their subsidiary to be adding the EuGeni Platform to their IVD offering. We welcome Vitro to the team and look forward to building a strong relationship with them over the coming years.”

     

    No tags.

    AnteoTech

    More posts by AnteoTech

    Related Post

    • Exxe Appointed as Italian Distributor

      By AnteoTech | 0 comment

      AnteoTech welcomes EXXE S.r.l (EXXE) to the EuGeni family. Based in Milan, Italy, EXXE is AnteoTech’s fifth European distributor for the EuGeni Reader platform and SARS-CoV-2 Antigen Rapid Diagnostic Test (RDT). We are excited atRead more

    • AnteoTech renews AnteoBind contract with Ellume

      By AnteoTech | 0 comment

      AnteoTech is pleased to advise that it has renewed its contract with leading healthcare diagnostic partner Ellume Ltd. (“Ellume”) for the supply of AnteoBind to be used in Ellume’s range of tests. Ellume is anRead more

    • Australian-made RATs await TGA approval amid rapid antigen test shortage

      By AnteoTech | 0 comment

      Australian-made RATs await TGA approval amid rapid antigen test shortage  Read more

    • How to make a Lithium-ion battery – Part 1

      By AnteoTech | 0 comment

      With our energy labs now expanded to accommodate new equipment enabling us to continue our in-house validation and testing of AnteoX we are pleased to share Part 1 of a three-part series on how weRead more

    • How to make a Lithium-ion battery – Part 2

      By AnteoTech | 0 comment

      Welcome to Part 2: Silicon anode coating, in our three-part series on how we make and test our Lithium-ion batteries here at AnteoTech. In this video, we create the anode by coating a copper currentRead more

    • How to make a Lithium-ion battery – Part 3

      By AnteoTech | 0 comment

      The final video in our three-part series on how we make and test our Lithium-ion batteries is the Assembly of the Battery. Our testing for both the AnteoX Cross-Linker & Binder Program and the high-performanceRead more

    • AnteoX recognised at the Australian Climate Technology Awards

      By AnteoTech | 0 comment

      AnteoTech Ltd is pleased to announce that its energy division and product AnteoX, have been recognised as an emerging leader at the 2022 Australian Technologies Competition (ATC). AnteoTech’s energy division which developed AnteoX, a uniqueRead more

    • AnteoTech receives second award at the Australian Technologies Competition

      By AnteoTech | 0 comment

      That’s two in a row! AnteoTech’s Clean Energy team has taken out the Manufacturing Innovation Award with its AnteoX product at the Australian Technologies Competition. Two separate judging panels have recognised the potential value inRead more

    NextPrevious

    Recent Posts

    • Advanced Automotive Battery Conference Presentation
    • AnteoTech receives second award at the Australian Technologies Competition
    • AnteoX recognised at the Australian Climate Technology Awards
    • How to make a Lithium-ion battery – Part 3
    • How to make a Lithium-ion battery – Part 2

    Recent Comments

      Quick Links

      • About
      • Life Science
      • Energy
      • Customer Login

      Investors

      • ASX Announcements
      • Corporate Governance & Company Policy
      • Financial Reporting
      • Share Price Information

      Contact Us

      If you have any general questions about our products or technology, contact customer support on (07) 3219 0085 or email contact@anteotech.com. For all technical support, please email support@anteotech.com.

      For all investor-related queries please email investors@anteotech.com.

      Copyright © AnteoTech 2021. All rights reserved. AnteoCoat/AnteoBind are trademarks of the AnteoTech group of companies. All other trademarks referenced are owned by their respective companies.
      Website by Start Digital
      • Home
      • About
        • BOARD OF DIRECTORS
        • MANAGEMENT TEAM
        • ADVISORY BOARDS
      • Life Science
        • ANTEOBIND
          • PUBLICATIONS
        • PRODUCTS
        • CONTRACT SERVICES
        • CASE STUDIES
        • WEBINARS
      • Energy
        • ANTEO X
        • WEBINARS
      • EuGeni
      • Newsroom
      • Investors
        • ASX ANNOUNCEMENTS
        • CORPORATE GOVERNANCE & COMPANY POLICY
        • VIEW ON ASX
      • Customer Login
      • Contact
      AnteoTech